Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Current Opinion in Immunology|February 2, 2010
Presentation of tumour antigens by dendritic cells and challenges facedNeil C Robson, Sabine Hoves, Eugene Maraskovsky, et al.European Journal of Immunology|April 10, 2008
Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cellsNeil C Robson, Anne M Donachie, Allan McI MowatImmunology|August 28, 2003
The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexesNeil C Robson, Helen Beacock-Sharp, Anne M Donachie, et al.Immunology|June 17, 2003
Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loadingNeil C Robson, Helen Beacock-Sharp, Anne M Donachie, et al.International Immunology|May 17, 2003
A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivoHelen Beacock-Sharp, Anne M Donachie, Neil C Robson, et al.Blood|January 15, 2009
Activin-A attenuates several human natural killer cell functionsNeil C Robson, Heng Wei, Tristan McAlpine, et al.Immunology and Cell Biology|April 22, 2009
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantEugene Maraskovsky, Max Schnurr, Nick S Wilson, et al.Blood|May 1, 2010
Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen deliveryNeil C Robson, Tristan McAlpine, Ashley J Knights, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase IIMax Schnurr, Martin Orban, Neil C Robson, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cellsAnja Helgeby, Neil C Robson, Anne M Donachie, et al.Pageof 2